PTGX Bathi mangsa ngarep Protagonist Therapeutics, Inc.

Protagonist Therapeutics Inc - logo grafis emiten PTGX

Protagonist Therapeutics develops advanced peptides for immunotherapy, becoming a critical component in the portfolios of industry behemoths, although environmental initiatives remain secondary for the company. This chart of expected business returns reconciles these priorities, where 0.12 serves as the current metric level. However, geopolitical risks and raw material supply disruptions create a certain vulnerability for business development.

PTGX: Prakiraan bathi perusahaan Protagonist Therapeutics 13.09.2025 - 26.02.2026

Rincian analitis perusahaan Protagonist Therapeutics

- rega saham lan konsensus proyeksi valuasi:
Analisis dhasar perusahaan:PTGX, Protagonist Therapeutics Inc
Barang utama Protagonist Corp

Monopoly patent ownership of peptide drugs in immunology provides Protagonist Therapeutics (PTGX) with a long-term rent-seeking model and highly protected revenues. When analyzing the company's future profit projections, investors assess the daily price action of the consensus net income forecast, which allows them to verify the business's financial resilience to inflationary shocks and determine the asset's real credit potential amid the revaluation of market assets.

Perusahaan pesaing

ARGX (argenx.com) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep BioNTech Group|Bathi mangsa ngarep ABVX (ABIVAX)|ADMA (ADMA Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep IMVT (immunovant.com)|Prakiraan bathi perusahaan kiniksa.com (KNSA)|GRFS - Bathi sing dikarepake|Adaptive Biotech (ADPT) - Bathi mangsa ngarep|Celldex Corp (CLDX) - Bathi sing dikarepake|Bathi mangsa ngarep Aurinia Pharmaceuticals|Bathi mangsa ngarep BCRX|Proyeksi bathi mangsa ngarep veratx.com|Bathi sing dikarepake Dianthus Pharma (DNTH)|Pharvaris - Prakiraan bathi resik|Proyeksi bathi mangsa ngarep ABCL (AbCellera)|Tourmaline Bio, Inc. (TRML) - Bathi resik sing dikarepake|PGEN - Bathi sing dikarepake|Bathi forward PHAR|NKTR: Proyeksi bathi mangsa ngarep|UPB - Prakiraan bathi perusahaan|Bathi sing dikarepake Zenas Biopharma Inc|Bathi mangsa ngarep Immunome, Inc. (IMNM)|Bathi sing dikarepake gossamerbio.com (GOSS)|Bathi sing dikarepake KALV (KalVista Pharmaceuticals)|Proyeksi bathi mangsa ngarep SEPN (Septerna Pharma)|Prakiraan bathi perusahaan Pieris Pharma (PVLA)|Savara Inc - Proyeksi bathi mangsa ngarep|Penghasilan resik sing dikarepake RIGL (Rigel Corp)|anaptysbio.com (ANAB) - Bathi sing dikarepake|Astria Therapeutics, Inc. - Penghasilan resik sing dikarepake|ENGN (enGene) - Proyeksi bathi mangsa ngarep|Bathi resik sing dikarepake RAPT Therapeutics Inc. RAPT|Bathi mangsa ngarep JBIO (Aerovate Therapeutics, Inc.)|Bathi resik mangsa ngarep ACRS|Proyeksi bathi mangsa ngarep KYTX (Kyverna Therapeutics)|Prakiraan bathi perusahaan Tiziana Life Sciences (TLSA)|Cabaletta Bio - Proyeksi bathi mangsa ngarep|Prakiraan bathi perusahaan Ventyx Biosciences, Inc. VTYX|Theratechnologies Inc (THTX) - Bathi sing dikarepake|Bathi forward AVTX (Avalo Therapeutics Inc.)|ELDN (Eledon Pharmaceuticals, Inc) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep agenusbio.com|Proyeksi bathi mangsa ngarep CLYM|Bathi resik mangsa ngarep ZURA|Proyeksi bathi mangsa ngarep ATYR (aTyr Pharmaceuticals)|Penghasilan resik sing dikarepake ADAG|ImageneBio Inc - Proyeksi bathi mangsa ngarep|STTK (shattucklabs.com) - Prakiraan bathi resik|EQ: Proyeksi bathi mangsa ngarep|Connect Biopharma Holdings (CNTB) - Proyeksi bathi mangsa ngarep|IMUX (immunic-therapeutics.com) - Proyeksi bathi mangsa ngarep|ATRA (Atara Biotherapeutics) - Bathi resik mangsa ngarep|Proyeksi bathi mangsa ngarep IFRX|Proyeksi bathi mangsa ngarep X4 Pharmaceuticals, Inc (XFOR)|Proyeksi bathi mangsa ngarep ACET (Adicet Bio Inc.)|CELU (Celularity Corp) - Bathi forward|INmune Bio Corp - Proyeksi bathi mangsa ngarep|BRNS - Proyeksi bathi mangsa ngarep|Kezar Life Sciences, Inc (KZR) - Bathi sing dikarepake|SABS (sabbiotherapeutics.com) - Bathi sing dikarepake|Bathi sing dikarepake Akari Therapeutics|Bathi sing dikarepake ENLV|Bathi sing dikarepake Q32 Bio Inc (QTTB)|GOVX (GeoVax Corp) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep EDSA (Edesa Biotech Corp)|IBIO: Prakiraan bathi resik|Carisma Therapeutics Inc. - Proyeksi bathi mangsa ngarep|XTLB: Bathi sing dikarepake|BOLT: Proyeksi bathi mangsa ngarep|Bathi mangsa ngarep HCW Biologics, Inc.|Bathi sing dikarepake aptevotherapeutics.com|Prakiraan bathi resik AIM (AIM ImmunoTech Inc.)|Bathi mangsa ngarep ADTX (Aditxt)|GRI (GRI Bio) - Penghasilan resik sing dikarepake|Proyeksi bathi mangsa ngarep XRTX (XORTX Therapeutics Inc)|Prakiraan bathi perusahaan Vyome Therapeutics (HIND)|REVB - Bathi sing dikarepake|INDP - Proyeksi bathi mangsa ngarep|SCNI: Proyeksi bathi mangsa ngarep|Prakiraan bathi resik CALI|AFMD (Affimed Therapeutics) - Proyeksi bathi mangsa ngarep|Proyeksi bathi mangsa ngarep allakos.com|Bathi mangsa ngarep HOOK (hookipapharma.com)|Bathi mangsa ngarep IGM Bio IGMS|Proyeksi bathi mangsa ngarep ITOS (iTeos Pharma)|OCEA - Bathi mangsa ngarep|TC BioPharm (Holdings) PLC - Proyeksi bathi mangsa ngarep|Third Harmonic Bio, Inc - Bathi resik mangsa ngarep